- Corporate Officers - B
- Bonney Michael W
Insider Trading History of Bonney Michael W
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bonney Michael W since 2015.
This trader's CIK number is 1219016.
At the time of last reporting, Bonney Michael W was the Director of Alnylam Pharmaceuticals, Inc.. (stock ticker symbol ALNY).
Also see all insider trading activities at Alnylam Pharmaceuticals, Inc..
Note that in the past
BONNEY MICHAEL W also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Kaleido Biosciences, Inc. (KLDO) by Bonney Michael W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | KLDO | 71,520 | $1,022,736 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Abrdn World Healthcare Fund (THW) by Bonney Michael W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | THW | 10,917 | $200,294 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Celgene Corp /de/ (CELG) by Bonney Michael W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CELG | 0 | $0 | 0 | $0 | 1,159 | $0 |
| 2018 | CELG | 0 | $0 | 0 | $0 | 675 | $0 |
| 2017 | CELG | 0 | $0 | 0 | $0 | 375 | $0 |
Yearly summary of insider trading at Sarepta Therapeutics, Inc. (SRPT) by Bonney Michael W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | SRPT | 2,000 | $173,480 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bristol Myers Squibb Co (BMY) by Bonney Michael W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | BMY | 0 | $0 | 0 | $0 | 3,851 | $0 |
| 2020 | BMY | 88 | $5,183 | 0 | $0 | 4,410 | $0 |
Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Bonney Michael W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ALNY | 0 | $0 | 22,500 | $8,168,051 | 22,500 | $2,265,862 |
| 2023 | ALNY | 0 | $0 | 36,448 | $7,040,952 | 52,477 | $2,893,500 |
| 2016 | ALNY | 2,000 | $116,720 | 0 | $0 | 0 | $0 |
| 2015 | ALNY | 2,000 | $224,320 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Bonney Michael W:
1. Kaleido Biosciences, Inc. (KLDO)
2. Abrdn World Healthcare Fund (THW)
3. Celgene Corp /de/ (CELG)
4. Sarepta Therapeutics, Inc. (SRPT)
5. Bristol Myers Squibb Co (BMY)
6. Alnylam Pharmaceuticals, Inc. (ALNY)
Table 1. Insider trading of Kaleido Biosciences, Inc. (KLDO) by Bonney Michael W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-02-28 | KLDO | Buy | 71,520 | 14.30 | 1,022,736 |
Table 2. Insider trading of Abrdn World Healthcare Fund (THW) by Bonney Michael W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-08-17 | THW | Buy | 10,917 | 18.35 | 200,294 |
Table 3. Insider trading of Celgene Corp /de/ (CELG) by Bonney Michael W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-13 | CELG | Option Ex | 484 | .00 | 0 |
| 2019-06-14 | CELG | Option Ex | 300 | .00 | 0 |
| 2019-06-15 | CELG | Option Ex | 375 | .00 | 0 |
| 2018-06-15 | CELG | Option Ex | 375 | .00 | 0 |
| 2018-06-14 | CELG | Option Ex | 300 | .00 | 0 |
| 2017-06-15 | CELG | Option Ex | 375 | .00 | 0 |
Table 4. Insider trading of Sarepta Therapeutics, Inc. (SRPT) by Bonney Michael W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-09-09 | SRPT | Buy | 2,000 | 86.74 | 173,480 |
Table 5. Insider trading of Bristol Myers Squibb Co (BMY) by Bonney Michael W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-13 | BMY | Option Ex | 902 | .00 | 0 |
| 2021-06-03 | BMY | Option Ex | 2,949 | .00 | 0 |
| 2020-06-13 | BMY | Option Ex | 903 | .00 | 0 |
| 2020-06-14 | BMY | Option Ex | 558 | .00 | 0 |
| 2019-12-04 | BMY | Buy | 88 | 58.90 | 5,183 |
| 2020-06-03 | BMY | Option Ex | 2,949 | .00 | 0 |
Table 6. Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Bonney Michael W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-18 | ALNY | Sale | 11,250 | 450.00 | 5,062,500 |
| 2025-08-18 | ALNY | Option Ex | 11,250 | 70.20 | 789,750 |
| 2025-05-15 | ALNY | Option Ex | 11,250 | 131.21 | 1,476,112 |
| 2025-05-15 | ALNY | Sale | 11,250 | 276.05 | 3,105,551 |
| 2023-12-27 | ALNY | Sale | 30,000 | 195.00 | 5,850,000 |
| 2023-12-27 | ALNY | Option Ex | 30,000 | 96.45 | 2,893,500 |
| 2023-08-03 | ALNY | Sale | 6,448 | 184.70 | 1,190,952 |
| 2023-08-02 | ALNY | Option Ex | 22,477 | .00 | 0 |
| 2016-03-09 | ALNY | Buy | 2,000 | 58.36 | 116,720 |
| 2015-05-12 | ALNY | Buy | 2,000 | 112.16 | 224,320 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bonney Michael W
(Director of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.